Jaffetilchin Investment Partners LLC Has $605,000 Stock Holdings in CME Group Inc. (NASDAQ:CME)

Jaffetilchin Investment Partners LLC lowered its position in CME Group Inc. (NASDAQ:CME) by 5.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,811 shares of the financial services provider’s stock after selling 154 shares during the quarter. Jaffetilchin Investment Partners LLC’s holdings in CME Group were worth $605,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in CME. Gold Investment Management Ltd. acquired a new position in shares of CME Group during the fourth quarter worth $26,000. Northwest Financial Advisors bought a new stake in shares of CME Group in the 4th quarter valued at about $28,000. Salomon & Ludwin LLC acquired a new stake in shares of CME Group in the first quarter valued at about $28,000. Harbor Investment Advisory LLC raised its position in shares of CME Group by 966.7% during the fourth quarter. Harbor Investment Advisory LLC now owns 160 shares of the financial services provider’s stock worth $34,000 after acquiring an additional 145 shares during the last quarter. Finally, Rise Advisors LLC bought a new position in shares of CME Group during the first quarter worth about $41,000. Institutional investors own 87.75% of the company’s stock.

Insider Activity

In other news, insider Hilda Harris Piell sold 7,140 shares of the business’s stock in a transaction that occurred on Wednesday, May 8th. The stock was sold at an average price of $210.35, for a total value of $1,501,899.00. Following the transaction, the insider now owns 29,256 shares in the company, valued at approximately $6,153,999.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other news, insider Hilda Harris Piell sold 7,140 shares of CME Group stock in a transaction on Wednesday, May 8th. The stock was sold at an average price of $210.35, for a total transaction of $1,501,899.00. Following the sale, the insider now directly owns 29,256 shares in the company, valued at approximately $6,153,999.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Terry L. Savage sold 2,500 shares of the firm’s stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $210.65, for a total transaction of $526,625.00. Following the sale, the director now owns 17,441 shares of the company’s stock, valued at approximately $3,673,946.65. The disclosure for this sale can be found here. Insiders sold a total of 14,290 shares of company stock worth $2,957,300 over the last quarter. Insiders own 0.30% of the company’s stock.

CME Group Stock Up 1.3 %

Shares of CME traded up $2.60 on Thursday, reaching $196.31. The company’s stock had a trading volume of 1,844,555 shares, compared to its average volume of 1,956,802. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $223.80. The stock has a market capitalization of $70.69 billion, a PE ratio of 22.48, a PEG ratio of 6.30 and a beta of 0.52. The company has a current ratio of 1.02, a quick ratio of 1.01 and a debt-to-equity ratio of 0.10. The firm has a fifty day moving average of $199.00 and a 200-day moving average of $206.99.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, topping the consensus estimate of $2.53 by $0.03. The firm had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. During the same period in the prior year, the business posted $2.30 earnings per share. The company’s quarterly revenue was up 12.7% compared to the same quarter last year. Equities analysts predict that CME Group Inc. will post 9.8 EPS for the current year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Friday, June 7th were paid a $1.15 dividend. The ex-dividend date of this dividend was Friday, June 7th. This represents a $4.60 annualized dividend and a dividend yield of 2.34%. CME Group’s payout ratio is 52.33%.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the stock. Morgan Stanley increased their target price on shares of CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a research report on Tuesday, April 9th. Rosenblatt Securities reaffirmed a “sell” rating and set a $187.00 price target (up previously from $185.00) on shares of CME Group in a research report on Thursday, April 25th. Deutsche Bank Aktiengesellschaft lowered their price objective on CME Group from $195.00 to $193.00 and set a “hold” rating for the company in a research report on Thursday, July 25th. Piper Sandler cut their target price on CME Group from $235.00 to $225.00 and set an “overweight” rating on the stock in a research report on Thursday, July 25th. Finally, Bank of America lifted their target price on CME Group from $209.00 to $216.00 and gave the stock a “neutral” rating in a report on Thursday, April 25th. Three research analysts have rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the stock. According to MarketBeat, CME Group currently has a consensus rating of “Hold” and a consensus target price of $212.64.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.